低头看我是怎么c哭你的,色午夜影院,国内午夜免费鲁丝片,小镇姑娘hd电影在线观看

Antithrombotic drugs

Time:2020-07-30  |   Frequency：

 

                                 

 

 

       Antithrombotic is the focus of drug research and development of Beijing Honghui New Pharmaceutical Technology Co., Ltd

       One of the domains includes anticoagulants and antiplatelet drugs, in which antiplatelet drugs are targeted

        We have set up a "R & D community" with foreign scientific research institutions, and are developing and developing it

        P2Y12 receptor reversible binding drugs, the goal is to improve the effectiveness of antithrombotic therapy and

        Reduce the patients taking ticagrelor and other similar adverse reactions.

                                         
 

 

    
       
       

 

                 

 

Representative antiplatelet drugs of P2Y12 receptor

 

 

Ticlopidine: irreversible adp-p2y12 receptor antagonist; Listed in 1991

 

 

Clopidogrel: irreversible adp-p2y12 receptor antagonist; Listed in 1997

 

 

Prasugrel: irreversible adp-p2y12 receptor antagonist; Listed in 2009

 

 

Ticagrelor: reversible adp-p2y12 receptor antagonist, oral; Listed in 2011

 

 

Cangrelor: reversible adp-p2y12 receptor antagonist, only for injection; Listed in 2015

  

 

 
 
 

Copyright © Beijing Honghui Meditech Co., Ltd   All Rights Reserved.   Tel：010-80456172，010-80456173    Address：Building 7, Liandong u Valley, No. 50, Huatuo Road, Daxing biomedical industrial base, Zhongguancun Science and Technology Park, Daxing District, Beijing